QDHC Quadramed Corp (MM)

QuadraMed® Corporation (NASDAQ:QDHC), a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, today announced the general availability of Quantim® Workflow, the newest addition to its suite of Quantim Health Information Management (HIM) solutions. Quantim Workflow is a scalable solution that enables single and multi-facility hospitals to automate the distribution and allocation of coding, compliance and other HIM work assignments, which can lead to increased productivity and reduced operational costs. Fox Chase Cancer Center, based in Philadelphia, is the initial facility to go live with QuadraMed’s web-native Quantim Workflow solution.

“Within two months of implementing Quantim Workflow, we reduced the level of outpatient bill holds related to claims coding by 73 percent, which led to a 62 percent reduction in accounts receivable (AR) days,” said Jackie Desiato, coding director, Fox Chase Cancer Center (FCCC). “The QuadraMed system has streamlined our operations by identifying and addressing coding and billing bottlenecks, prioritizing coding assignments, and assigning our highest dollar and complex cases to our most skilled coders.”

Quantim Workflow automatically distributes assignments and documents to client-defined worklists, enabling healthcare organizations to accurately distribute work, and leverage advanced coding skills through selective assignment of work items. Additionally, Quantim Workflow provides healthcare organizations with productivity and aging reports, as well as comprehensive audit trails, for expanded coder accountability related to workload quantity and quality.

“QuadraMed’s Workflow solution, combined with the rules and exception queue, enables our facility to present the outpatient coding staff with new work every day. By streamlining our coder workflow, we eliminated the need to look at the same accounts over and over again and reduced the duplicate examinations of cases already coded that had not yet dropped from the paper report. This leap in productivity helps us to maintain current coder staffing levels and effectively allocate their time to exceptions or higher priority cases,” added Desiato.

“Quantim® Workflow helps enhance and accelerate revenue cycle management processes and is an ideal add-on application for clients using Quantim Coding,” said Duncan W. James, QuadraMed's President and CEO. “By driving greater operational and administrative efficiencies, this solution can directly impact the bottom line of healthcare providers – helping to ensure long-term viability.”

The QuadraMed Quantim Workflow solution integrates with the entire suite of Quantim solutions, which include: coding, compliance, electronic document management, correspondence management for release of information, chart completion, and electronic signature.

About Fox Chase Cancer Center

Founded in 1904 in Philadelphia as one of the nation's first Cancer hospitals, Fox Chase is one of the leading Cancer research and treatments centers in the United States. Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit www.fccc.edu.

About QuadraMed Corporation

QuadraMed – (NASDAQ: QDHC) is a leading provider of healthcare technologies and services that help turn quality care into positive financial outcomes. QuadraMed provides innovative solutions that streamline revenue management and compliance processes, while helping healthcare professionals deliver quality patient care. Behind the Company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit www.Quadramed.com.

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. The words “believe,” “expect,” “target,” “goal,” “project,” “anticipate,” “predict,” “intend,” “plan,” “estimate,” “may,” “will,” “should,” “could” and similar expressions and their negatives are intended to identify such statements. Forward-looking statements are not guarantees of future performance, anticipated trends or growth in businesses, or other characterizations of future events or circumstances and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including the risks faced by QuadraMed described in documents filed with the Securities and Exchange Commission ("SEC") from time to time. QuadraMed’s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC’s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.

Quadramed Corp (MM) (NASDAQ:QDHC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Quadramed Corp (MM) (NASDAQ:QDHC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024